A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.
Garcia-Casado Z, Guerrero-Zotano A, Llombart-Cussac A, Calatrava A, Fernandez-Serra A, Ruiz-Simon A, Gavila J, Climent MA, Almenar S, Cervera-Deval J, Campos J, Albaladejo CV, Llombart-Bosch A, Guillem V, Lopez-Guerrero JA.
Garcia-Casado Z, et al. Among authors: albaladejo cv.
BMC Cancer. 2010 Feb 9;10:36. doi: 10.1186/1471-2407-10-36.
BMC Cancer. 2010.
PMID: 20144226
Free PMC article.